All Stories

  1. Five year mortality in an RCT of a lung cancer biomarker to select people for low dose CT screening
  2. Conceptualisation of health among young people: a protocol for systematic review and thematic synthesis of qualitative studies
  3. Guidelines and regulations applicable to vitro diagnostic tests in the UK: a scoping review
  4. Health Economic Evaluation of Lung Cancer Screening Using a Diagnostic Blood Test: The Early Detection of Cancer of the Lung Scotland (ECLS)
  5. Improved five year mortality in an RCT of a lung cancer biomarker to select people for screening
  6. Health economic evaluation of lung cancer screening using a diagnostic blood test: the Early detection of Cancer of the Lung Scotland (ECLS)
  7. Are treatment services ready for the use of big data analytics and artificial intelligence in managing opioid use disorder?: Viewpoint Paper (Preprint)
  8. Captured by design: the drug industry and UK healthcare
  9. Conceptualisation of health among young people: a protocol for systematic review and thematic synthesis of qualitative studies
  10. Long-term exposure to air pollution and mortality in Scotland: A register-based individual-level longitudinal study
  11. Tonsillectomy compared with conservative management in patients over 16 years with recurrent sore throat: the NATTINA RCT and economic evaluation
  12. Breast Cancer Screening Among Females With and Without Schizophrenia
  13. Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role?
  14. Intranasal steroid use and COVID-19 mortality among patients with asthma and COPD
  15. Optimising recruitment to a lung cancer screening trial: A comparison of general practitioner and community-based recruitment
  16. ‘You feel like you’ve been duped’: is the current system for health professionals declaring potential conflicts of interest in the UK fit for purpose? A mixed methods study
  17. Conservative management versus tonsillectomy in adults with recurrent acute tonsillitis in the UK (NATTINA): a multicentre, open-label, randomised controlled trial
  18. Progressing social prescribing with a focus on process of connection: Evidence-informed guidance for robust evaluation and evidence synthesis
  19. Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years
  20. The spatial–temporal effect of air pollution on individuals’ reported health and its variation by ethnic groups in the United Kingdom: a multilevel longitudinal analysis
  21. Diabetes care among individuals with and without schizophrenia in three Canadian provinces: A retrospective cohort study
  22. Working collaboratively to design an instructional video for an at home blood sample collection kit
  23. Union formation and fertility amongst immigrants from Pakistan and their descendants in the United Kingdom: A multichannel sequence analysis
  24. Factors associated with recruitment to randomised controlled trials in general practice: a systematic mixed studies review
  25. Emulating a Target Trial Using Primary-Care Electronic Health Records: Sodium-Glucose Cotransporter 2 Inhibitor Medications and Hemoglobin A1c
  26. Understanding patient barriers and facilitators to uptake of lung screening using low dose computed tomography: a mixed methods scoping review of the current literature
  27. ‘Delicate diagnosis’: avoiding harms in difficult, disputed, and desired diagnoses
  28. Efficacy of Prednisolone for Bell Palsy in Children
  29. How are declarations of interest working? A cross-sectional study in declarations of interest in healthcare practice in Scotland and England in 2020/2021
  30. Optimizing the implementation of lung cancer screening in Scotland: Focus group participant perspectives in the LUNGSCOT study
  31. Understanding multimorbidity trajectories in Scotland using sequence analysis
  32. Tayside Screening For Cardiac Events (TASCFORCE) study: a prospective cardiovascular risk screening study
  33. Marginal Structural Models Using Calibrated Weights With SuperLearner: Application to Type II Diabetes Cohort
  34. OP16 The effect ofair pollution on individuals’ mental well-being in the United Kingdom: a spatial-temporal longitudinal study
  35. Does Long-Term Air Pollution Exposure Affect Self-Reported Health and Limiting Long Term Illness Disproportionately for Ethnic Minorities in the UK? A Census-Based Individual Level Analysis
  36. Assessment of background levels of autoantibodies as a prognostic marker for severe SARS-CoV-2 infection
  37. Increasing uptake to a lung cancer screening programme: building with communities through co-design
  38. Psychological impact of lung cancer screening using a novel antibody blood test followed by imaging: the ECLS randomized controlled trial
  39. Exposure to ambient air pollution is linked to poor mental well-being
  40. Development of an algorithm to classify primary care electronic health records of alcohol consumption: experience using data linkage from UK Biobank and primary care electronic health data sources
  41. Social prescribing and behaviour change: proposal of a new behaviour change technique concerning the ‘connection’ step
  42. Bell’s Palsy
  43. Early experience with an opt-in research register - Scottish Health Research Register (SHARE): a multi-method evaluation of participant recruitment performance
  44. Studying trajectories of multimorbidity: a systematic scoping review of longitudinal approaches and evidence
  45. Using Electronic Medical Records to Identify Potentially Eligible Study Subjects for Lung Cancer Screening with Biomarkers
  46. Can we achieve better recruitment by providing better information? Meta-analysis of ‘studies within a trial’ (SWATs) of optimised participant information sheets
  47. P95 Capturing patient reported outcome measures (PROMs) and health data from smart devices: attitudes of the general public
  48. No association between previous autoantibody expression and development of SARS-CoV-2.
  49. Targeted screening for lung cancer with autoantibodies
  50. Presumed consent and sharing medical data: Scottish register allows researchers to approach patients
  51. Abstract book for SAPC ASM 2021
  52. Abstract Anne H Berman – incoming ISBM president
  53. Realising the full potential of data-enabled trials in the UK: a call for action
  54. Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial
  55. A systematic review of the application of machine learning methods for patient recruitment through electronic health records (Preprint)
  56. Over‐use of thyroid testing in Canadian and UK primary care in frequent attenders: A cross‐sectional study
  57. Efficient Identification of Patients Eligible for Clinical Studies Using Case-Based Reasoning on The Scottish Health Research Register (SHARE)
  58. Trends in diabetes medication use in Australia, Canada, England, and Scotland: a repeated cross-sectional analysis in primary care
  59. Early diagnosis of lung cancer in people most at risk
  60. Studying trajectories of multimorbidity: a systematic scoping review of longitudinal approaches and evidence
  61. The effect of air-pollution and weather exposure on mortality and hospital admission and implications for further research: A systematic scoping review
  62. Methods of connecting primary care patients with community‐based physical activity opportunities: A realist scoping review
  63. Information and rational decision-making: explanations to patients and citizens about personal risk of COVID-19
  64. Cardiovascular risk factor documentation and management in primary care electronic medical records among people with schizophrenia in Ontario, Canada: retrospective cohort study
  65. Recording COVID-19 consultations: review of symptoms, risk factors, and proposed SNOMED CT terms
  66. P34 Socioeconomic disparities in the development of multimorbidity in Scotland: the benefits of applying a life course longitudinal approach
  67. P81 Social patterning of self-reported health among 10–24-year-olds across the UK countries: a preliminary analysis of the 2001 and 2011 Censuses
  68. Early diagnosis of lung cancer with an autoantibody test.
  69. Connecting primary care patients to community-based physical activity: a qualitative study of health professional and patient views
  70. Clinical Decision Support Systems for Opioid Prescribing for Chronic Non-Cancer Pain in Primary Care: A Scoping Review
  71. Point-of-care tests for urinary tract infections: protocol for a systematic review and meta-analysis of diagnostic test accuracy
  72. Efficient identification of patients eligible for clinical studies using case-based reasoning on Scottish Health Research register (SHARE)
  73. Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing
  74. Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is needed
  75. Effect on Treatment Adherence of Distributing Essential Medicines at No Charge
  76. The “All of Us” Research Program
  77. Do statins have an effect on depressive symptoms? A systematic review and meta-analysis
  78. PL02.03 Early Detection of Cancer of the Lung Scotland (ECLS): Trial Results
  79. Antiviral treatment for Bell's palsy (idiopathic facial paralysis)
  80. Unconditional and conditional monetary incentives to increase response to mailed questionnaires: A randomized controlled study within a trial (SWAT)
  81. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
  82. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
  83. The Impact of Treatment Adherence for Patients With Diabetes and Hypertension on Cardiovascular Disease Risk: Protocol for a Retrospective Cohort Study, 2008-2018
  84. Factors associated with recruitment to randomised controlled trials in general practice: protocol for a systematic review
  85. Participatory governance over research in an academic research network: the case of Diabetes Action Canada
  86. The Impact of Treatment Adherence for Patients With Diabetes and Hypertension on Cardiovascular Disease Risk: Protocol for a Retrospective Cohort Study, 2008-2018 (Preprint)
  87. Agreement between primary care and hospital diagnosis of schizophrenia and bipolar disorder: A cross-sectional, observational study using record linkage
  88. Podiatry interventions to prevent falls in older people: a systematic review and meta-analysis
  89. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
  90. Trends in end digit preference for blood pressure and associations with cardiovascular outcomes in Canadian and UK primary care: a retrospective observational study
  91. Determinants of motivation to quit in smokers screened for the early detection of lung cancer: a qualitative study
  92. Primary care providers’ views on a future lung cancer screening program
  93. Impact of the Diabetes Canada Guideline Dissemination Strategy on the Prescription of Vascular Protective Medications: A Retrospective Cohort Study, 2010–2015
  94. Identifying top 10 primary care research priorities from international stakeholders using a modified Delphi method
  95. Lung cancer CT screening: Psychological responses in the presence and absence of pulmonary nodules
  96. An instrument to identify computerised primary care research networks, genetic and disease registries prepared to conduct linked research: TRANSFoRm International Research Readiness (TIRRE) survey
  97. Lung cancer screening: does pulmonary nodule detection affect a range of smoking behaviours?
  98. The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial
  99. Principles and operational model for governing Diabetes Action Canada's data repository for patient-oriented research
  100. Prevalence and Distribution of Atherosclerosis in a Low- to Intermediate-Risk Population: Assessment with Whole-Body MR Angiography
  101. Development and Validation of a Path Length Calculation for Carotid–Femoral Pulse Wave Velocity Measurement
  102. Canada’s future health care system
  103. Agreement between hospital and primary care on diagnostic labeling for COPD and heart failure in Toronto, Canada: a cross-sectional observational study
  104. Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)?
  105. Strategies to improve recruitment to randomised trials
  106. Finding and using routine clinical datasets for observational research and quality improvement
  107. Serum and blood based biomarkers for lung cancer screening: a systematic review
  108. Systemic arteriosclerosis is associated with left ventricular remodeling but not atherosclerosis: a TASCFORCE study
  109. Would you like to add a weight after this blood pressure, doctor? Discovery of potentially actionable associations between the provision of multiple screens in primary care
  110. Piloting electronic screening forms in primary care: findings from a mixed methods study to identify patients eligible for low dose CT lung cancer screening
  111. Late Breaking Abstract - An interim report on the detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test in Scotland (ECLS)
  112. The PRECIS-2 tool has good interrater reliability and modest discriminant validity
  113. Podiatry intervention versus usual care to prevent falls in care homes: pilot randomised controlled trial (the PIRFECT study)
  114. Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial
  115. 15 No association between systemic arteriosclerosis and atherosclerosis on cardiac MRI and whole body angiography: the tascforce study
  116. Reply
  117. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial
  118. Oral and Topical Antibiotics for Clinically Infected Eczema in Children: A Pragmatic Randomized Controlled Trial in Ambulatory Care
  119. Bell’s Palsy in Children (BellPIC): protocol for a multicentre, placebo-controlled randomized trial
  120. Cohort profile: the Scottish Research register SHARE. A register of people interested in research participation linked to NHS data sets
  121. P2.06-038 An RCT of the Detection of Autoantibodies to Tumor Antigens in Lung Cancer Using the EarlyCDT-Lung Test in Scotland (ECLS) in 12 208 Study Subjects
  122. A primary care Web-based Intervention Modeling Experiment replicated behavior changes seen in earlier paper-based experiment
  123. Stepping Up to the Plate: An Agenda for Research and Policy Action on Electronic Medical Records in Canadian Primary Healthcare
  124. S132 A randomised controlled study of lung cancer screening in scotland using the detection of autoantibodies to tumour antigens (earlycdt-lung test)
  125. ‘Thinking that somebody's going to delay [a tonsillectomy] for one to two years is quite horrifying really’: a qualitative feasibility study for the NAtional Trial of Tonsillectomy IN Adults (NATTINA Part 2)
  126. Left Ventricular Noncompaction
  127. A young woman with acute one-sided facial paralysis
  128. Antiviral Agents Added to Corticosteroids for Early Treatment of Adults With Acute Idiopathic Facial Nerve Paralysis (Bell Palsy)
  129. Prevalence of unrecognized myocardial infarction in a low–intermediate risk asymptomatic cohort and its relation to systemic atherosclerosis
  130. Opt-in method is vital for data sharing
  131. Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial
  132. Corticosteroids for Bell's palsy (idiopathic facial paralysis)
  133. Management of Bell's palsy
  134. Identifying risk factors for progression to critical care admission and death among individuals with acute pancreatitis: a record linkage analysis of Scottish healthcare databases
  135. Text mining describes the use of statistical and epidemiological methods in published medical research
  136. 3T MRI investigation of cardiac left ventricular structure and function in a UK population: The tayside screening for the prevention of cardiac events (TASCFORCE) study
  137. Defining Disease Phenotypes in Primary Care Electronic Health Records by a Machine Learning Approach: A Case Study in Identifying Rheumatoid Arthritis
  138. 015 Prevalence, pattern and significance of late gadolinium enhancement in a healthy asymptomatic cohort
  139. Atomic data: James Mackenzie Lecture 2015
  140. A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: the ChildRen with Eczema, Antibiotic Management (CREAM) study
  141. Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio‐T2DM cohort study
  142. A practical application of a novel software solution to aid identification of research participants in primary care - the CREAM study (children with eczema antibiotic management study)
  143. Do pragmatic trials trade-off internal validity for external validity?
  144. Matching trial design decisions to the needs of those you hope will use the results: the PRECIS-2 tool
  145. Antiviral treatment for Bell's palsy (idiopathic facial paralysis)
  146. Accuracy of Patient Self-Report of Stroke: A Systematic Review from the UK Biobank Stroke Outcomes Group
  147. Antiviral treatment for Bell's palsy (idiopathic facial paralysis)
  148. Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis
  149. Antiviral treatment for Bell's palsy (idiopathic facial paralysis)
  150. Antiviral treatment for Bell's palsy (idiopathic facial paralysis)
  151. The NAtional randomised controlled Trial of Tonsillectomy IN Adults (NATTINA): a clinical and cost-effectiveness study: study protocol for a randomised control trial
  152. Technical assessment of whole body angiography and cardiac function within a single MRI examination
  153. The PRECIS-2 tool: designing trials that are fit for purpose
  154. Antiviral treatment for Bell's palsy (idiopathic facial paralysis)
  155. Using Electronic Health Records to Support Clinical Trials: A Report on Stakeholder Engagement for EHR4CR
  156. The John Bryden memorial lecture: improving health with the community health index and developments in record linkage
  157. Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index
  158. The GP as an investigator
  159. Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study
  160. Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial
  161. Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts
  162. Primary care research network progress in Scotland
  163. Paper-based and web-based intervention modeling experiments identified the same predictors of general practitioners' antibiotic-prescribing behavior
  164. Why do women not return family history forms when referred to breast cancer genetics services? A mixed-method study
  165. Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects
  166. Acceptability and perceived barriers and facilitators to creating a national research register to enable ’direct to patient’ enrolment into research: the Scottish Health Research Register (SHARE)
  167. Impact of clinical trial findings on Bell's palsy management in general practice in the UK 2001–2012: interrupted time series regression analysis
  168. An ethnographic exploration of influences on prescribing in general practice: why is there variation in prescribing practices?
  169. Unlocking the research potential of the GP electronic care record
  170. Developing a survey instrument to assess the readiness of primary care data, genetic and disease registries to conduct linked research: TRANSFoRm International Research Readiness (TIRRE) survey instrument
  171. Lessons from Mackenzie that still resonate
  172. Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose
  173. Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis
  174. The Utility of Liver Function Tests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI)
  175. Commentary: A thesis that still warrants defence and promotion
  176. Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study
  177. Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
  178. Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings
  179. 2011 RCGP and Novartis Research Paper of the Year
  180. E-mail invitations to general practitioners were as effective as postal invitations and were more efficient
  181. Insightful practice: a reliable measure for medical revalidation
  182. Factors that promote or inhibit the implementation of e-health systems: an explanatory systematic review
  183. Electronic health records: research into design and implementation
  184. 2010 RCGP & Novartis Research Paper of the Year
  185. The University of Dundee
  186. Using Web Technology to Support Population-Based Diabetes Care
  187. Tacit and transitionary: An exploration of patients’ and primary care health professionals’ goals in relation to asthma
  188. Developing and evaluating interventions to reduce inappropriate prescribing by general practitioners of antibiotics for upper respiratory tract infections: A randomised controlled trial to compare paper-based and web-based modelling experiments
  189. Evaluating the Angina Plan in Patients Admitted to Hospital with Angina: A Randomized Controlled Trial
  190. Dermatology research in primary care: why, what, and how?
  191. The Research Paper of the Year Award 2009
  192. Commentary on: ‘The research agenda for general practice/family medicine and primary health care in Europe. Part 4. Specific problem solving skills’
  193. Strategies to improve recruitment to randomised controlled trials
  194. Developing a longitudinal database of routinely recorded primary care consultations linked to service use and outcome data
  195. Strategies to improve recruitment to randomised controlled trials
  196. A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell's palsy: the BELLS study
  197. Bell's palsy: new evidence provides a definitive drug therapy strategy
  198. Structure investigation of the (100) surface of the orthorhombicAl13
  199. Health outcomes following liver function testing in primary care: a retrospective cohort study
  200. Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)
  201. Economic evaluation of early administration of prednisolone and/or aciclovir for the treatment of Bell's palsy
  202. Prescribe prednisolone alone for Bell's palsy diagnosed within 72 hours of symptom onset
  203. A secure electronic diary and data collection tool
  204. PG11 THE DEVELOPMENT AND PERFORMANCE OF MODELS TO PREDICT RISK OF LIVER DISEASE DIAGNOSIS FOLLOWING LIVER FUNCTION TESTING IN PRIMARY CARE
  205. PG119 THE COST-UTILITY OF LIVER DISEASE DIAGNOSIS: ASSESSING GP DECISIONS FOR PATIENTS WITH ABNORMAL LIVER FUNCTION TESTS AND NO OBVIOUS LIVER DISEASE
  206. The accuracy of symptoms, signs and diagnostic tests in the diagnosis of left ventricular dysfunction in primary care: A diagnostic accuracy systematic review
  207. Treatment for Bell's palsy
  208. Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study
  209. Family caregivers of older relatives: Ways of coping and change in distress
  210. Perindopril plus indapamide reduced death and major macrovascular and microvascular events in type 2 diabetes
  211. Assuring the confidentiality of shared electronic health records
  212. Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia
  213. Diagnosis of left ventricular systolic dysfunction (LVSD): development and validation of a clinical prediction rule in primary care
  214. Early Treatment with Prednisolone or Acyclovir in Bell's Palsy
  215. Understanding the implementation and integration of e-health services
  216. Primary care research networks in the United Kingdom
  217. Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)
  218. A lifestyle intervention continued to prevent type 2 diabetes in high risk patients after the programme was stopped
  219. Recruitment and retention in a multicentre randomised controlled trial in Bell's palsy: A case study
  220. A critical re‐appraisal of different ways of selecting ambulatory patients with suspected heart failure for echocardiography
  221. Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis
  222. Specific drug therapies during pregnancy
  223. Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability
  224. Familial breast cancer: management of ‘lower risk’ referrals
  225. e-Prescribing, Efficiency, Quality: Lessons from the Computerization of UK Family Practice
  226. Emergency Preparedness for Pandemic Influenza
  227. Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations
  228. How much does pre-trial testing influence complex intervention trials and would more testing make any difference? An email survey
  229. Receiver operating characteristics of the prostate specific antigen test in an unselected population
  230. An extra pair of hands? Evaluation of salaried payment for general practitioners
  231. Is the involvement of opinion leaders in the implementation of research findings a feasible strategy?
  232. Adherence to antihypertensive medication and association with patient and practice factors
  233. eHealth and the future: promise or peril?
  234. Agreement between community echocardiography and hospital echocardiography in patients suspected of having left ventricular systolic dysfunction
  235. Communication and navigation around the healthcare system
  236. Control, compare and communicate: designing control charts to summarise efficiently data from multiple quality indicators
  237. Improving services with informatics tools
  238. Keeping up: learning in the workplace
  239. Referral or follow-up?
  240. How computers help make efficient use of consultations
  241. How informatics tools help deal with patients' problems
  242. How computers can help to share understanding with patients
  243. How decision support tools help define clinical problems
  244. Why is this patient here today?
  245. Is a consultation needed?
  246. What is health information?
  247. Efficacy and Tolerability of Tricyclic Antidepressants and SSRIs Compared With Placebo for Treatment of Depression in Primary Care: A Meta-Analysis
  248. The Tayside children's sleep questionnaire: a simple tool to evaluate sleep problems in young children
  249. A study of telephone screening and direct observation of surgical wound infections after discharge from hospital
  250. Secondary prevention of heart disease with statins
  251. What Is eHealth (4): A Scoping Exercise to Map the Field
  252. Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials
  253. The social and psychological impact of an older relative's hearing difficulties: Factors associated with change
  254. Recent developments in Bell's palsy: Trial for Bell's palsy is in progress in Scotland
  255. Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data
  256. Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas
  257. Do the British Guidelines for Asthma Management facilitate concordance?
  258. The social and psychological impact of an older relative's hearing difficulties
  259. Electronic Clinical Communications Implementation (ECCI) in Scotland: a mixed‐methods programme evaluation
  260. A retrospective, study of prescribing for erectile dysfunction in a UK population during 1997–2000: demand was neither excessive nor continuing to rise
  261. Optimal strategies for identifying patients with myocardial infarction in general practice
  262. DARTS 2000 online diabetes management system: formative evaluation in clinical practice
  263. Four years of TayRen, a primary care research and development network
  264. Systematic review of scope and quality of electronic patient record data in primary care
  265. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis
  266. Screening for depression in primary care
  267. Critical Issues in Peripheral Arterial Disease Detection and Management<subtitle>A Call to Action</subtitle>
  268. Effect of computerised evidence based guidelines
  269. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer
  270. The RCP’s ‘Three Key Questions’ for asthma: review of practical use
  271. What is health informatics?
  272. Contraindications to metformin therapy in patients with Type 2 diabetes—a population‐based study of adherence to prescribing guidelines
  273. A descriptive feast but an evaluative famine: systematic review of published articles on primary care computing during 1980-97
  274. NHSnet in Scottish primary care: lessons for the future
  275. Audit encourages an evidence-based approach to medical practice
  276. Evidence-based education: development of an instrument to critically appraise reports of educational interventions
  277. Perceptions of Guidelines in Primary and Secondary Care: Implications for Implementation
  278. CD Rom: Current Medical Diagnosis and Treatment 1998
  279. Principles of epidemiological research on drug effects
  280. Informatics in medical education
  281. Area‐wide diabetes care: the Lanarkshire experience with primary health care teams 1994–1997
  282. What can universities do to reverse the decline in the numbers of doctors entering general practice?
  283. Audit in general practice: educating medical students
  284. The Assessment of Higher Level Cognitive Objectives in Undergraduate Medical Students Using a Clinical Audit Project
  285. Evidence in consultations: interpreted and individualised
  286. Videotaping of general practice consultations
  287. Has general practitioner computing made a difference to patient care? A systematic review of published reports
  288. Videotaping of general practice consultations: effect on patient satisfaction
  289. Intruders in the consultation
  290. The Role of General Practitioners in Diabetic Eye Care in Lanarkshire
  291. Audit: teaching medical students in general practice
  292. Should practice nurses be involved in diabetic care?
  293. Primary Medical Care in Seychelles
  294. The Productive Use of Threat in Primary Care: Behavioural Responses to Health Promotion
  295. Children seen frequently out of hours in one general practice.
  296. The costs and benefits of introducing a nurse‐run diabetic review service into general practice
  297. Rheumatology at the general practitioner/hospital interface: a study of prevalence and access to specialist care.
  298. Using insulin U 100 conversion to estimate the prevalence and problems of insulintreated diabetic patients in the Republic of Seychelles
  299. CLINICAL PRACTICE NEW REFERRALS TO RHEUMATOLOGY CLINICS–WHY DO THEY KEEP COMING BACK?
  300. Effect of a Reading List on Reading Habits of General Practitioners
  301. The Medical Outcomes Study Instrument (MOSI)—Use of a New Health Status Measure in Britain
  302. Care of Diabetic Patients in the Republic of Seychelles
  303. Whose Problem is the Diabetic Who Does Not Attend a Hospital Clinic?
  304. Assessment of disability caused by rheumatic diseases in general practice.
  305. Problems of comprehensive shared diabetes care
  306. Create and maintain an age-sex register.
  307. Do most practices have an age-sex register?
  308. Medical patients aged 65 and over admitted to an accident and emergency department
  309. Pharmacokinetics of Human Insulin Zinc Suspension (Recombinant DNA) in Normal Man: A Comparison with Porcine Insulin Zinc Suspension
  310. Diabetes and Insurance: A Survey of Patient Experience
  311. Effects of continued pentaerythritol tetranitrate administration on myocardial circulation and metabolism
  312. 143 Effect of isoniazid on the production of tuberculous immunity
  313. THE EFFECT OF TREATMENT WITH A LARGE DOSE OF ISONIAZID ON AN ESTABLISHED TUBERCULOUS INFECTION IN MICE
  314. THE EFFECT OF CORTISONE ON THE MULTIPLICATION OF M. TUBERCULOSIS IN NORMAL AND IMMUNE MICE